Prognostic Factors for Melanoma

Oliver J. Wisco; Arthur J. Sober

doi:10.1016/j.det.2012.04.008

Prognostic Factors for Melanoma

Oliver J. Wisco, Arthur J. Sober

Dermatology

Research output: Contribution to journal › Review article › peer-review

29 Scopus citations

Abstract

The current melanoma staging system, as defined by the American Joint Committee on Cancer (AJCC), is the standard by which melanoma prognosis is determined. This article focuses on the components of the AJCC melanoma staging system regarding patient prognosis. In addition, this article summarizes the other commonly researched clinical and histologic melanoma prognostic factors and reviews the recent advancements in genetic biomarkers associated with prognosis.

Original language	English (US)
Pages (from-to)	469-485
Number of pages	17
Journal	Dermatologic Clinics
Volume	30
Issue number	3
DOIs	https://doi.org/10.1016/j.det.2012.04.008
State	Published - Jul 1 2012

Keywords

Biomarkers
Histology
Melanoma
Prognosis
Survival

ASJC Scopus subject areas

Dermatology

Access to Document

10.1016/j.det.2012.04.008

Cite this

@article{f34c96fa8be24826a812f8edbf534ad0,

title = "Prognostic Factors for Melanoma",

abstract = "The current melanoma staging system, as defined by the American Joint Committee on Cancer (AJCC), is the standard by which melanoma prognosis is determined. This article focuses on the components of the AJCC melanoma staging system regarding patient prognosis. In addition, this article summarizes the other commonly researched clinical and histologic melanoma prognostic factors and reviews the recent advancements in genetic biomarkers associated with prognosis.",

keywords = "Biomarkers, Histology, Melanoma, Prognosis, Survival",

author = "Wisco, {Oliver J.} and Sober, {Arthur J.}",

year = "2012",

month = jul,

day = "1",

doi = "10.1016/j.det.2012.04.008",

language = "English (US)",

volume = "30",

pages = "469--485",

journal = "Dermatologic Clinics",

issn = "0733-8635",

publisher = "W.B. Saunders Ltd",

number = "3",

}

TY - JOUR

T1 - Prognostic Factors for Melanoma

AU - Wisco, Oliver J.

AU - Sober, Arthur J.

PY - 2012/7/1

Y1 - 2012/7/1

N2 - The current melanoma staging system, as defined by the American Joint Committee on Cancer (AJCC), is the standard by which melanoma prognosis is determined. This article focuses on the components of the AJCC melanoma staging system regarding patient prognosis. In addition, this article summarizes the other commonly researched clinical and histologic melanoma prognostic factors and reviews the recent advancements in genetic biomarkers associated with prognosis.

AB - The current melanoma staging system, as defined by the American Joint Committee on Cancer (AJCC), is the standard by which melanoma prognosis is determined. This article focuses on the components of the AJCC melanoma staging system regarding patient prognosis. In addition, this article summarizes the other commonly researched clinical and histologic melanoma prognostic factors and reviews the recent advancements in genetic biomarkers associated with prognosis.

KW - Biomarkers

KW - Histology

KW - Melanoma

KW - Prognosis

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=84863870578&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863870578&partnerID=8YFLogxK

U2 - 10.1016/j.det.2012.04.008

DO - 10.1016/j.det.2012.04.008

M3 - Review article

C2 - 22800552

AN - SCOPUS:84863870578

SN - 0733-8635

VL - 30

SP - 469

EP - 485

JO - Dermatologic Clinics

JF - Dermatologic Clinics

IS - 3

ER -

Prognostic Factors for Melanoma

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this